Neogen Chemicals Ltd
BSE:542665

Watchlist Manager
Neogen Chemicals Ltd Logo
Neogen Chemicals Ltd
BSE:542665
Watchlist
Price: 2 322.3501 INR 2.09% Market Closed
Market Cap: ₹61.3B

Wall St Price Targets

NEOGEN Price Targets Summary
Neogen Chemicals Ltd

Wall Street analysts forecast NEOGEN stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NEOGEN is 1 892.5116 INR with a low forecast of 1 463.109 INR and a high forecast of 2 607.2225 INR.

Lowest Forecast
Price Target
1 463.109 INR
37% Downside
Average Forecast
Price Target
1 892.5116 INR
19% Downside
Highest Forecast
Price Target
2 607.2225 INR
12% Upside
Neogen Chemicals Ltd Competitors:
Price Targets

Revenue
Forecast

24% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
24% / Year
Past Growth
29% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Over the last 10 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 7 years is 29%.

Gross Profit
Forecast

29% / Year
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss
29% / Year
Past Growth
35% / Year
Estimated Growth
Estimates Accuracy
-25%
Average Miss

Over the last 10 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 7 years is 35%.

Operating Income
Forecast

25% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
25% / Year
Past Growth
31% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 10 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 7 years is 31%.

Pre-Tax Income
Forecast

20% / Year
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
20% / Year
Past Growth
48% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 48%.

Net Income
Forecast

21% / Year
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss
21% / Year
Past Growth
41% / Year
Estimated Growth
Estimates Accuracy
-8%
Average Miss

Over the last 10 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 7 years is 41%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is NEOGEN's stock price target?
Price Target
1 892.5116 INR

According to Wall Street analysts, the average 1-year price target for NEOGEN is 1 892.5116 INR with a low forecast of 1 463.109 INR and a high forecast of 2 607.2225 INR.

What is the Revenue forecast for Neogen Chemicals Ltd?
Projected CAGR
29%

Over the last 10 years, the compound annual growth rate for Revenue has been 24%. The projected CAGR for the next 7 years is 29%.

What is the Gross Profit forecast for Neogen Chemicals Ltd?
Projected CAGR
35%

Over the last 10 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 7 years is 35%.

What is the Operating Income forecast for Neogen Chemicals Ltd?
Projected CAGR
31%

Over the last 10 years, the compound annual growth rate for Operating Income has been 25%. The projected CAGR for the next 7 years is 31%.

What is the Pre-Tax Income forecast for Neogen Chemicals Ltd?
Projected CAGR
48%

Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 20%. The projected CAGR for the next 3 years is 48%.

What is the Net Income forecast for Neogen Chemicals Ltd?
Projected CAGR
41%

Over the last 10 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 7 years is 41%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett